Beyni'ni "Akıllıca" ve "Ahlaklıca" Kullananlara...

Error message here!

Göster Error message here!

Şifreni mi unuttun?

Close

Göster

Göster

Şifreni mi unuttun? Lütfen e-mail adresinizi giriniz. Yeni bir şifre oluşturmak için bir link alacaksınız.

Giriş Yap

X
Alan Smith

Prof.Dr.Gülsen Babacan Yıldız

Nöroloji Uzmanı



EDUCATION


BUSINESS EXPERIENCE

Nevşehir, Cappadocia Public Hospital, 1993-1995

Lundbeck Pharmaceutical Company. Sep. 2007-Feb 2009

Bezmiâlem University Faculty of Medicine,Department of Neurology. Sep. 2010-May 2013

Bezmiâlem University Faculty of Medicine, Department of Neurology. May 2013-Feb 2019

Bezmiâlem University Faculty of Medicine, Department of Neurology. Feb 2019-Onward


MEMBERSHIPS


THESIS  


THESIS  ADVISOR


TEACHING EXPERIENCE 


PUBLICATIONS 

  1. Yildizhan Sengul, Hakan Serdar Sengul, Elif Gokcal, Ismet Ustun, Ahmet Ozturk, Onur Yilmaz, Gulsen B. Yıldız & Elan D. Louis. Neurological Research DOI: 10.1080/01616412.2020.1792702. 2020
  2. Abdulkadir Tunç, Azize Esra Gürsoy, Vildan Güzel, Elif Gökçal, Gülsen Babacan Yıldız. Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever. Acta Neurol Belg 120, 687–688. 2020
  3. Merve Çebi, Gülsen Babacan, Öget Öktem Tanör & Hakan Gürvit  Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer’s disease dementia: The Turkish standardization study, Journal of Clinical and Experimental Neuropsychology, 42:5, 450-458. 2020
  4. Uslu FI, Elif G, Gürsoy AE, Kolukisa M, Yıldız GB. Creutzfeldt-Jakob Disease: A single center experience and systemic analysis of cases in Turkey. Ideggyogyaszati Szemle. May;73 (05-06):177-184. 2020
  5. Bektay M. Y. ,Gökçe M., Selvitop R., Bolat E., Yıldız G. B. , -Investigation of the associatoin between polypharmacy and Alzheimer disease-, International journal of clinical pharmacy, cilt.42, ss.283. 2020
  6. Tugcu, B., Melikov, A., Yildiz, G.Babacan. et al. Evaluation of retinal alterations in Parkinson disease and tremor diseases. Acta Neurol Belg 120, 107–113. 2020 
  7. Atasoy B., Aralasmak A., Cetinkaya E., Toprak H., Toprak A., Tokdemir S., Babacan G., Alkan A., Normal Pressure Hydrocephalus: Clinical Symptoms, Cerebrospinal Fluid Flow Metrics and White Matter Changes.-, Journal of computer assisted tomography, cilt.44, ss.59-64. 2020
  8. K Wojta, M Filippi, GW Small, AL Boxer, BL Miller, G Coppola, AH Ayer, F Agosta, EM Ramos, D Dokuru, JA Chen, AM Karydas, JD Papatriantafyllou, D Agiomyrgiannakis, V Kamtsadeli, N Tsinia, D Sali, KH Gylys, DA Bennett, M Gearing, JL Juncos, J Kramer, SE Lee, JS Yokoyama, MF Mendez, H Chui, C Zarow, JM Ringman, U Kilic, Gülsen Babacan-Yıldız, A Levey, CS DeCarli, CW Cotman. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.-, Alzheimer disease and associated disorders, cilt.33, ss.327-330, 2019
  9. Kilic U, Elibol B, Uysal O, Kilic E, Yulug B, Sayin Sakul A, Babacan Yıldız G. Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia. Exp Gerontol. Oct 1;111:203-209. 2018
  10. Baran G., Gultekin T., Baran O., Deniz C., Katar S., Babacan Yıldız G., et al.,"Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study.", Neuropsychiatric Disease and Treatment, vol.14, pp.757-766, 2018
  11. Baran G, Deniz Ç, Gürsoy AE, Babacan Yıldız G. Asymmetric Blepharospasm. Bezmialem Science 2018. DOI: 10.14235/bs.2018.1931. 2018
  12. Babacan Yıldız G ,  Yacı Ö,  Akça Z,  Baral-Kulaksızoğlu I.  Reliability and Validity of the Abbreviated Turkish Version of the Zarit Caregiver Burden Interview.Bezmialem Science. 4: 60-64). DOI: 10.14235/bs.2016.489. 2016
  13. Gökçal E, Babacan-Yıldız G .  Treatment of Motor Symptoms in Idiopathic Parkinson’s Disease. Bezmialem Science ; 3: 43-47. DOI: 10.14235/bs. 2015
  14. G.Babacan-Yıldız, E. Ur-Özçelik, M. Kolukisa, E. Gursoy G. Kocaman, A. Celebi. Validity and Reliability Studies of Modified Mini Mental State Examination (MMSE-E) For Turkish Illiterate Patients With Diagnosis of Alzheimer Disease. Türk Psikiyatri Dergisi; 26. 2015
  15. G.Babacan-Yıldız, A.T. Isik, E. Ur, E. Aydemir, C. Ertas,M. Cebi, P. Soysal, E. Gursoy, M. Kolukisa, G. Kocaman A. Celebi. COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients. International Psychogeriatrics. 1-10; 10.1017/ S1041610212001780.2012
  16. G.Babacan-Yıldız, H. Hanagası, H.Gurvıt, G.Sirin, S.Solakoglu,O. Su Kucuk. A rare dementing disease: Adult Neuronal Ceroid Lipofuscinoses. The Journal of Neuropsychiatry and Clinical Neurosciences. ; 24:1–6. 2012
  17. G.Babacan-Yıldız, E.Gürsoy, M.Kolukisa, F.Karaköse, E.Akkoyunlu, A.Celebi, E. Lohmann. Clinical features of a large Turkish pedigree with Restless Leg Syndrome and Periodic Limb Movements. Sleep and Breathing International Journal of the Science and Practice of Sleep Medicine. Aug 2. 2012
  18. G.Babacan-Yıldız, E. Gursoy, M. Kolukisa, and A. Celebi. Restless Legs Syndrome Responsive to Rasagiline Treatment: A Case Report. Clinical Neuropharmacology. Volume 35, Number 2, March/April 2012. 
  19. G.Babacan-Yıldız. Non-Alzheimer Dementias 1: Primary Progressive Aphasia. Review. Geriatr Neuropsychiatr 2011;2 (2-3):28-34.
  20. G.Babacan-Yıldız. Non-Alzheimer Dementias 2: Frontotemporal Dementias. Review. Geriatr Neuropsychiatr 2012;3 (1):9-14
  21. G.Babacan-Yıldız, A. Çoban, H. Hanağası, H. Gürvit, J. Yazıcı. Differences Between  Essential Tremor And  Essential Tremor Developing Parkinson’s Disease. Archives of Neuropsychiatry 2010;47(2):101-4
  22. G.Babacan-Yıldız,  AE.Gürsoy, A.Güneri. Botulinum Toxin Type-A Application for the Treatment of Cervical Dystonia. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi. 2012;15(1):1-6. 
  23. G. Babacan. Alzheimer Hastalığında Klinik Semptomlar. Sendrom. Aktüel Tıp Dergisi. Ocak / Şubat 2011. Nöroloji, 23(1):27-30, 2011.
  24. AE Gürsoy, G Babacan- Yıldız, M Kolukisa, A Celebi. Idiopathic spinal accessory nerve palsy: A case report and review of the literature. Neurology India. Jan-Feb 2013, Vol: 61 Issue 1
  25. Soysal P, Isik AT, Uğur A, Kazancioglu R, Ergun F, Babacan Yıldız G. Vitamin B12 and folic acid levels are not related to length of stay in elderly inpatients. Nutrition. 2013 Jan 9. pi: S0899-9007(12)00401-7
  26. A.T.Isik, G.Babacan Yıldız, E.Bozoglu, A.Yay, E.Aydemir. Cardiac Safety of Donepezil in Elderly Patients with Alzheimer Disease. Internal Medicine. 51: 575-578, 2012. 
  27. AE Gürsoy, M Kolukısa, G.Babacan-Yıldız, Ö Altıntas, A Yaman, T Asil. Reversible conduction failure in overlap of Miller Fisher syndrome and pharyngeal–cervical–brachial variant of Guillain-Barré syndrome in the spectrum of nodo-paranodopathies. Clin Neurosci. 2014, 
  28. Gürsoy AE, Babacan-Yıldız G, Kolukısa M, Asil T, Ertaş M. Neuromuscular transmission impairment in transient global amnesia. Feb 5.  2013
  29. E. Lohmann, B. Dursun, S. Lesage, H. A. Hanagasi, G. Sevinc, A. Honore, B. Bilgic,H. Gurvit, O. Dogu, H.Kaleagası, G. Babacan, J. Yazici, N. Erginel-Unaltuna, A. Brice and M. Emre. Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. European Journal of Neurology. 19: 769–775. 2012
  30. AE. Gürsoy, M. Kolukısa, G. Babacan YıldızG.Kocaman, A.Çelebi. Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS  pain scale in carpal tunnel syndrome. Neuropsychiatric Disease and Treatment :9 65–71. 2013
  31. AE Gürsoy, G.Babacan Yıldız, A.M.Gülhan, M.KolukisaHemifacial Spasm due to Compression of the Posterior Inferior Cerebellar Artery Aneurysm Treated with Botulinum Toxin Type-A: A Case Report. Case Report Neurol Med. 132594.2012
  32. AE Gürsoy, I. Ugurad, G.Babacan Yıldız,  M.Kolukisa, A.Çelebi. Effects of botulinum toxin type a on quality of life assessed with the WHOQOL-BREF in hemifacial spasm and blepharospasm. Neurol  Psychiatry  Brain  Res. 2012. 
  33. P.Soysal, G.Babacan-Yıldız, A.T.Isık. Pituitary insufficiency: A cause of hypoglycemia in an elderly diabetic patient.Geriatr Gerontol Int. Feb 2. 2012
  34. AE.Gürsoy, G.Babacan-Yıldız. Botulinum Toksin Tip A Tedavisine Yanıtlı Derin Beyin Stimülasyonu Sonrası Geç Dönem Ortaya Çıkan Göz Kapağı Açma Apraksisi. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi. 15(1):21-25. doi: 10.5606/ phhb. dergisi.05.2012
  35. B. Oflazoğlu, H. Forta , Ç. Öncel, G. Babacan Yıldız. Demiyelinizan Polinöropatilerde İntravenöz İmmünglobulin G’nin Etkinliği. Düşünen Adam. 18(4):196-204. 2005
  36. M. Çelik, H. Forta, Türker Dalkılıc¸G. Babacan. MRI reveals reversible lesions resembling posterior reversible encephalopathy in  porphyria. Neuroradiology;44: 839–841. 2002
  37. M. Basak, M. Erturk, B. Oflazoğlu, A. Ozel, G. Babacan Yıldız, H. Forta. Magnetic resonance imaging in ALS. Acta Neurol Scand. 105:395–399. ISSN 0001-6314.2002


SCIENTIFIC EXPERT REVIEWER 


BOOKS 

  1. Babacan-Yıldız G., Editör, "Semptomdan Teşhise Nöroloji", Nobel Tıp Kitabevi,  2020
  2. Babacan-Yıldız G., Editör, "Nörolojinin ABC’si ", İstanbul Tıp Eğitim Kitabevi,  2018


BOOK CHAPTERS

  1. G.Babacan-Yıldız, "A Neurologist’s Perspective ", in: Approach to the Elderly Patient with Delirium, Ahmet Turan Isik, George T. Grossberg, Eds., Springer International Publishing AG. Switzerland 2018, Cham, pp.77-87, 2018
  2. Elif Gökçal & G.Babacan-Yıldız, "Frontotemporal Demansda Ayırıcı Tanı", Editor: Nerses Bebek, O'TIP, İstanbul, ss.200-210, 2015
  3. G.Babacan-Yıldız, "Parkinson Hastalığında Tedavi", Geriatri Pratiğinde İlaç Tedavisi, Turan Işık A, Editor, OTIP, İstanbul, ss.200-222, 2015
  4. Babacan-Yıldız G., "Posterior Kortikal Atrofi ", G.Babacan-Yıldız. Editor: Tanrıdağ O., Davranış Nörolojisi, Nobel Tıp Kitabevi, İSTANBUL, ss.200-221, 2015
  5. G.Babacan-Yıldız, Editor: Oğuz Tanrıdağ Davranış Nörolojisi. (Davranışsal  Varyant Frontotemporal Demans), İstanbul.2015 
  6. Elif Gökçal & G.Babacan-Yıldız, Editör: Oğuz Tanrıdağ Davranış Nörolojisi. (Lewy Cisimcikli Demans), İstanbul. 2015 
  7. G.Babacan-Yıldız. Editor: A.Turan Işık, Pınar Soysal. MMSE, SÇT. İstanbul Tıp Kitabevleri.̇ İstanbul. 2016 
  8. G.Babacan-Yıldız. Editor: A.Turan Işık, Turgay Çelik. Geriatri Pratiğinde İlaç Tedavisi . Parkinson Hastalığ Tedavisi. Nobel. 2015. 
  9. G.Babacan-Yıldız, Editör: A.Turan Işık, “Her Yönüyle Alzheimer Hastalığı” (Alzheimer Hastalığı Kliniği: Kognitif Semptomlar), 267-285 pp., İstanbul, SOM, 2012.
  10. G.Babacan-Yıldız, Editör: A.Turan Işık, “Her Yönüyle Alzheimer Hastalığı“ (Alzheimer Hastalığında Nörokognitif Testler), 321-368 pp., İstanbul, SOM, 2012.


PHASE III and POST MARKETING STUDIES

  1. International Merck-MK8931-017 (Prime investigator, 2014)
  2. International Lundbeck-14861A, 14862A and 14863A (Prime investigator, 2014)
  3. International Lilly-H6L-MC-LFBC-LY450139 (Sub investigator, 2009)
  4. International Pfizer-Dimebon-NCT00912288 (Sub investigator, 2009)
  5. International Novartis-Exelon CENA713DA (Sub investigator, 2007)
  6. National Exelon Novartis-CENA713B2315 (Sub investigator, 2007)
  7. International Lundbeck-Ebixa in Lewy Body Dementia (Sub investigator, 2007)
  8. International Novartis-Stalevo First-Step (Sub investigator,2006)
  9. International Novartis-Stalevo Stride-PD (Sub investigator, 2005)


NEUROPSYCHOLOGICAL TESTS 

  1. Addenbrooke’s Cognitive Examination-Revised (ACE-R) 
  2. Alzheimer’s Disease Assessment Scale cognitive subscale (ADAS-Cog)
  3. Beck Depression Inventory (BDI)
  4. Boston Naming Test (BNT)
  5. Clinical Dementia Rating Scale (CDR) 
  6. Clinicians’ Interview-Based Impression of Change (CIBIC) 
  7. Clinicians’ Interview–Based Impression of Change-Plus (CIBIC+)
  8. Clock Drawing Test (CDT) 
  9. Facial Recognition Test 
  10. Geriatric Depression Scale (GDS)
  11. Global Deterioration Scale (GDS) 
  12. Line Orientation Test
  13. Mini Mental State Examination (MMSE) 
  14. Montreal Cognitive Assessment (MoCA)
  15. Neuropsychiatric Inventory (NPI)
  16. Severe Impairment Battery (SIB)
  17. Trail Making Test (TMT) 
  18. Short Test of Mental Status (STMS)
  19. Zarit Caregiver Burden


PERSONAL DATA